In a report released Monday, the Government Accountability Office says the BioWatch system has issued dozens of false alarms since its introduction. It recommends that Homeland Security, which oversees the system, hold off any upgrades until the department can be sure of BioWatch's current capabilities.
The BioWatch system was implemented in 2003, two years after five people died and 20 others were sickened by letters containing anthrax spores. The system involves aerosol collectors deployed in 30 U.S. cities, including on top of buildings and in subways and airports. Personnel remove filters from each of the detectors and check them for the presence of airborne pathogens, a process that can take up to 36 hours. The program operated with an $87 million budget last year, according to the GAO.
Homeland Security has proposed replacing the manual detectors with a more automated system — what it calls a lab-in-a-box — that would reduce detection time to six hours.
But the GAO says Homeland Security hasn't developed performance requirements to adequately test the current system and is unable to "draw conclusions about the system's ability to detect attacks."
The BioWatch system has been plagued by "false positives," totaling 149 between 2003 and 2014, according to the GAO.
In an interview with the Los Angeles Times, the GAO's chief scientist and the report's lead author, Timothy M. Persons, said that:
"Health and public-safety authorities 'need to have assurance that when the system indicates a possible attack, it's not crying wolf.' U.S. Homeland Security officials cannot credibly offer that assurance, he said. 'You can't claim it works.' "
A Homeland Security spokesman had this response to the GAO's findings:
"The Department of Homeland Security's BioWatch program is the only federally-managed, locally-operated nationwide bio-surveillance system designed to detect select aerosolized biological agents and remains a critical part of our nation's defense against biological threats.
While DHS appreciates the GAO's effort in identifying the best practices of the BioWatch program, DHS does not agree with all of GAO's characterizations of our BioWatch efforts. Nonetheless, the Department concurs with the four recommendations in the GAO report, and has already implemented or is in the process of implementing efforts that will fulfill the recommendations."
KELLY MCEVERS, HOST:
Since the terrorist attacks in Paris, there are concerns about possible gaps in this country's bioterror detection system. In a report released today, the government accountability office says homeland security can't really tell how well the system works. Here's NPR's Brian Naylor.
BRIAN NAYLOR, BYLINE: After the threat of bioterrorism became real when five Americans were killed and 20 injured by letters containing anthrax spores in 2001, the government moved to set up a system to detect a widescale bioterror attack. Called BioWatch, the system involved aerosol collectors deployed in 30 U.S. cities - on top of buildings, in subways and at airports. Filters from each of the detectors are removed daily and checked for the presence of airborne pathogens, a process that can take up to 36 hours.
Homeland security wants to upgrade the current system known as Gentoo to a newer model that would take much less time to determine whether a bioterrorist attack was underway. But the GAO report says it's not clear how well the devices work now because Homeland Security's testing is inadequate, and so it makes little sense to upgrade the unproven system. Timothy Persons is the GAO's lead scientist and coauthor of the report.
TIMOTHY PERSONS: The department does not have reliable information about the technical capabilities of Gentoo to detect an attack and therefore doesn't have the basis for an informed cost-benefit analysis about whether to upgrade the system or whether to move to some new technology.
NAYLOR: To BioWatch system has been plagued by false positives totaling 149 between 2003 and 2014, according to the GAO. In a statement, the Department of Homeland Security says it does not agree with all of the GAO's characterizations of the BioWatch program but is implementing its recommendations just the same. Brian Naylor, NPR News, Washington. Transcript provided by NPR, Copyright NPR.